ALK+ International (@alkpositiveint) 's Twitter Profile
ALK+ International

@alkpositiveint

Charity focused on funding & advocating for #research to improve the life expectancy of ALK+ #CancerPatients. #TogetherWeCan further ALK+ cancer research

ID: 1498702548999577604

linkhttps://www.alkinternational.org/ calendar_today01-03-2022 16:52:17

2,2K Tweet

1,1K Followers

1,1K Following

OncoDaily (@oncodaily) 's Twitter Profile Photo

A Journey of Hope: Norman Ng’s Inspiring Story In this episode of OncoInfluencers, Jemma Arakelyan interviews lung cancer survivor Norman Ng, who shares his journey with stage 4 lung cancer, his advocacy work, and his efforts in advancing ALK inhibitors in Hong Kong while

A Journey of Hope: Norman Ng’s Inspiring Story

In this episode of OncoInfluencers, <a href="/JArakelyan28092/">Jemma Arakelyan</a>  interviews lung cancer survivor Norman Ng, who shares his journey with stage 4 lung cancer, his advocacy work, and his efforts in advancing ALK inhibitors in Hong Kong while
CancerNetwork® (@cancernetwrk) 's Twitter Profile Photo

Dr. Edward Garon discusses the circumstances that might lead him to switch a patient with ALK+ NSCLC from another ALK inhibitor to lorlatinib. #NSCLC cancernetwork.com/view/evaluatin…

Dr. Robert (@robt_heartdoc) 's Twitter Profile Photo

Hidehito HORINOUCHI Nature Reviews Cancer OncoAlert ALK Positive The review's deep dive into ALK's oncogenic role and emerging resistance to inhibitors is a call to action for innovative cancer therapies. As a cardiologist, I champion the need for sustained research investment, crucial for advancing patient care amidst the UK's challenging

Teens get cancer too (@trials4now) 's Twitter Profile Photo

Ultra-deep sequencing of high-risk neuroblastomas found oncogenic aberrations are more prevalent at diagnosis than once thought. ALK and RAS pathway aberrations confer inferior outcomes, emphasizing the need for novel therapeutic approaches. ascopost.com/news/march-202…

Compound Researcher (@compoundarxiv) 's Twitter Profile Photo

Cascade-responsive nano-PROTACs for tumor-specific ALK protein degradation and enhanced cancer therapy sciencedirect.com/science/articl…

GRACE (@cancergrace) 's Twitter Profile Photo

Now Dr. Jennifer A. Marks, MD presenting Biomarker Testing 101 for Lung Cancer at our Targeted Therapies in Lung Cancer. What is a #biomarker? #ALk #ROS1 #LungCancer #TargetedTherapies #cancerGRACE #CancerEducation

GRACE (@cancergrace) 's Twitter Profile Photo

Dr. Karen Yun presenting: How Do You Read a Molecular Testing Report? What are Driver Alterations in Lung Cancer? #TargetedTherapiesInLungCancer #LungCancer #ALK #ROS1 #RET #NTRK #EGFR #BRAF #MET #HER2 #KRAS

H. Jack West, MD, FASCO (@jackwestmd) 's Twitter Profile Photo

We at GRACE are fortunate to have Christine Bestvina from UChicagoCancerCenter speaking on ALK, ROS1, and RET at our Targeted Therapies forum. She has become deservedly recognized for her thoughtful commentary in many areas of lung cancer. Many options to consider here.

We at <a href="/cancerGRACE/">GRACE</a> are fortunate to have <a href="/ChristineBestv1/">Christine Bestvina</a> from <a href="/UCCancerCenter/">UChicagoCancerCenter</a> speaking on ALK, ROS1, and RET at our Targeted Therapies forum. She has become deservedly recognized for her thoughtful commentary in many areas of lung cancer. Many options to consider here.
Dr Akhil Santhosh (@tuttsakhil) 's Twitter Profile Photo

ALK-EML4 fusion in small cell lung cancer: Clinical and molecular insights from a rare case - Lung Cancer Lung Cancer Journal lungcancerjournal.info/article/S0169-…

Upstage Lung Cancer (@upstagelungcanc) 's Twitter Profile Photo

🎙 NEW PODCAST EPISODE! The Riddle Of Drug Response. Today, we speak with Dr. Zachary Rogers, a post-doctoral researcher at MIT’s Koch Institute, whose work on ALK mutations illuminates these advancements. Listen: upstagelungcancer.org/podcasts & on all podcast platforms! #Lilly #Bayer

🎙 NEW PODCAST EPISODE! The Riddle Of Drug Response. Today, we speak with Dr. Zachary Rogers, a post-doctoral researcher at MIT’s Koch Institute, whose work on ALK mutations illuminates these advancements. Listen: upstagelungcancer.org/podcasts &amp; on all podcast platforms!
#Lilly #Bayer
ALK+ International (@alkpositiveint) 's Twitter Profile Photo

ALK+ International is looking for Volunteers! Passionate about ALK+ cancer research? Social media experience? Want to get involved with advocacy? If you believe that research saves lives come and join our team and help us further ALK+ cancer research. #Action4Alk #TogetherWeCan

ALK+ International is looking for Volunteers!
Passionate about ALK+ cancer research? Social media experience? Want to get involved with advocacy?

If you believe that research saves lives come and join our team and help us further ALK+ cancer research. 
#Action4Alk
#TogetherWeCan
EGFR Positive Lung Cancer UK (@egfruk) 's Twitter Profile Photo

MARIPOSA shows a 25% OS benefit for amivantamab + lazertinib vs osimertinib in newly diagnosed EGFR+ advanced #lungcancer. A big moment—but not a simple one. Side effects, IV treatment & QoL all matter. And right now, this option isn’t available for those in our UK EGFR+

MARIPOSA shows a 25% OS benefit for amivantamab + lazertinib vs osimertinib in newly diagnosed EGFR+ advanced #lungcancer.

A big moment—but not a simple one. Side effects, IV treatment &amp; QoL all matter.

And right now, this option isn’t available for those in our UK EGFR+
ALK+ International (@alkpositiveint) 's Twitter Profile Photo

ALK+ International are now signed up to Recycle4charity! ♻️🦑 Recycle4Charity is a free programme for empty ink cartridges!- help the environment whilst raising money for much-needed research into ALK+ cancer! Donations of up to £2 per ink cartridge recycle4charity.co.uk/register/C1605…

ALK+ International are now signed up to Recycle4charity! ♻️🦑

Recycle4Charity is a free programme for empty ink cartridges!- help the environment whilst raising money for much-needed research into ALK+ cancer! Donations of up to ÂŁ2 per  ink cartridge 

recycle4charity.co.uk/register/C1605…
ALK+ International (@alkpositiveint) 's Twitter Profile Photo

ALK+ International needs you to invest in hope today and donate to vital medical research into ALK+ cancer. Like, share and follow us across all social media platforms to show your support 💙🩵🩷 Whatever you do, big or small makes a difference, join us and take #ACTION4ALK

ALK+ International (@alkpositiveint) 's Twitter Profile Photo

ALK+ International is proud to introduce it's new weekly lottery! 🎰 ALK+ International receives 40% of ticket price regardless of winner status so why not give it a try today and be in to win up to £25,000! 💸👛💸 givinglottery.org.uk/support/alk-in… #Action4Alk #TogetherWeCan

ALK+ International is proud to introduce it's new weekly lottery! 🎰
<a href="/ALKpositiveINT/">ALK+ International</a>  receives 40% of ticket price regardless of winner status so why not give it a try today and be in to win up to £25,000! 💸👛💸

givinglottery.org.uk/support/alk-in…

#Action4Alk

#TogetherWeCan